Skip to main content

Doctors could one day diagnose Alzheimer’s with a simple eye exam

 

It’s hard to overstate how devastating neurodegenerative diseases like Alzheimer’s can be. But while there is no cure for Alzheimer’s yet, early diagnosis that results in earlier treatment can help to delay its progression. Today, a doctor diagnosing Alzheimer’s would likely do so through a combination of memory tests, blood tests (to rule out other reasons for memory being affected), and a CT scan. However, in the future it could conceivably be as simple as carrying out a relatively basic eye test. This may speed up diagnosis since it could show positive results before the onset of symptoms.

Recommended Videos

“[In our new work] we found evidence of neurofilament light chain (NfL) in eye fluid,” Manju Subramanian, an ophthalmologic surgeon at Boston Medical Center, told Digital Trends. “Increased levels of NfL are detectable in blood and cerebrospinal fluid in conditions such as Alzheimer’s and Parkinson’s Disease.”

Subramanian noted that it is too early to confirm if the eye could indeed be a source of diagnosis, although she described this as a “foundational” study for such work to be explored later on. The Boston Medical Center study is the first time that NfL, which is biomarker for diagnosis of certain neurodegenerative diseases, has been found in the eye.

“The eye is an extension of the brain, and as an optical system, the eye can provide a direct window to visualize disease,” she said. “Many diseases that affect the central nervous system can also affect the eye. As such, direct sampling of ocular fluid for quantification of biomarkers may provide a uniquely accessible and cost-effective means for diagnosis.”

The researchers in the study collected eye fluid samples from 77 patients undergoing eye surgery at Boston Medical Center. All 77 patients tested positive for the presence of NfL.

Neurodegenerative diseases are currently on the rise around the world as many people are living longer than before. Alzheimer’s remains the most common disease in this category, affecting around 5.5 million Americans today. Parkinson’s is less common, but still affects over one million people in the United States. It’s too early to jump to conclusions about how this work could potentially impact these numbers. However, every piece of research in this area represents a step in the right direction. This is definitely research to follow.

A paper describing the work was recently published in the journal Alzheimer’s Research & Therapy.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Elizabeth Olsen says that Marvel movies are ‘not really the art I consume’
Elizabeth Olsen as the Scarlet Witch in Doctor Strange in the Multiverse of Madness.

For almost a decade, Elizabeth Olsen's Scarlet Witch was a mainstay in the Marvel Cinematic Universe. After first being introduced in 2014's Captain America: The Winter Soldier, Olsen went on to star in several other Marvel films and even her own TV show. In a recent interview with NPR's Wild Card With Rachel Martin, Olsen said that she is still working to prove to the rest of Hollywood that she's more than just Marvel.

“I think I haven’t always successfully made choices in my work that are aligned with my personal taste and that is something I feel like I’m still trying to prove when I meet people,” Olsen said, explaining that her work as Scarlet Witch has shaped how the public sees her. “Especially if it’s a work type meeting and be able to express my personal taste in films and literature, and so I still think I have that to prove.”

Read more
Fantastic Four director says there are ‘no other superheroes’ in the universe of his movie
The Fantastic 4 stand on a platform in "The Fantastic Four: First Steps"

As Marvel ramps up toward Avengers: Doomsday, one of the big new additions to that cast will be the Fantastic Four. We've gotten our first glimpse at the heroes, who occupy their own retro-futuristic universe.

Now, director Matt Shakman is providing some more details on that universe, and just how far removed it is from the rest of the MCU.

Read more
Alan Cumming says that he’s ‘excited and amazed’ to be able to return to Nightcrawler
Alan Cumming as Nightcrawler in X2

There were plenty of expected names in the extended cast reveal for Avengers: Doomsday, along with a few notable absences. Perhaps the most surprising addition to the cast, though, was the return of many of the original Fox X-Men from the early 2000s trilogy. Among the most notable actors returning are Patrick Stewart, Ian McKellan, James Marsden, Rebecca Romjin, and Alan Cumming, who played Nightcrawler in X2: X-Men United.

In a recent interview with Jenna Bush-Hager and Olivia Munn, Cumming said that he was excited to be able to step back into the character after more than 20 years.

Read more